Clinical Trials Logo

Disease clinical trials

View clinical trials related to Disease.

Filter by:

NCT ID: NCT01554176 Terminated - Clinical trials for Major Depressive Disorder, Recurrent

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022)

Start date: May 18, 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of filorexant (MK-6096) versus placebo as adjunctive treatment for major depressive disorder (MDD), in participants who are partial responders to antidepressant monotherapy with one of identified selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs), or bupropion. The primary hypothesis of the study is that filorexant is superior to placebo as augmentation therapy with respect to change from baseline to Week 6 in the Montgomery Asberg Depression Rating Scale (MADRS) total score.

NCT ID: NCT01553240 Terminated - Clinical trials for Autism Spectrum Disorder

Neurocircuitry of Autism- fMRI and Transcranial Magnetic Stimulation Studies

Start date: June 2007
Phase: N/A
Study type: Interventional

This study uses functional brain imaging and noninvasive brain stimulation techniques to study the brain basis of developmental disorders like Autism Spectrum Disorder and Asperger Disorder. Functional magnetic resonance imaging (fMRI) and recently approved FDA treatment of depression, Transcranial magnetic stimulation (TMS) will be used to study the neurocircuitry of certain symptom clusters in developmental disorders.

NCT ID: NCT01551225 Completed - Clinical trials for Irritable Bowel Syndrome

Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic Disorder

Start date: January 2012
Phase: Phase 4
Study type: Interventional

This study will be executed according to a randomized double-blind placebo-controlled trial with two parallel groups, treated over the period of 6 months with escitalopram or placebo. Hypotheses: Escitalopram is more effective than placebo in the control of gastrointestinal symptoms, in irritable bowel syndrome (IBS) patients with panic disorder. Escitalopram is more effective than placebo in the control of psychiatric symptoms, in IBS patients with panic disorder.

NCT ID: NCT01547481 Completed - Clinical trials for REM Sleep Behavior Disorder

MRI Study of Brain Activity in Healthy Adults and Individuals With Parkinsonism and Rapid Eye Movement Disorder.

Start date: December 2011
Phase:
Study type: Observational

This proposal is focused on developing a reliable, valid, and reproducible imaging techniques and statistical methodology for segregation of various forms of Parkinsonism from healthy adults without Parkinsonism.

NCT ID: NCT01547000 Completed - Tourette Syndrome Clinical Trials

Guanfacine in Children With Tic Disorders

Start date: April 2012
Phase: Phase 4
Study type: Interventional

The goal of this pilot study is to obtain preliminary information on the tolerability and efficacy of extended release guanfacine (trade name Intuniv) in children with Tourette Disorder (TD, also called Tourette syndrome).

NCT ID: NCT01544400 Terminated - Anorexia Nervosa Clinical Trials

Description and Evaluation of Eating Disorders in Elite Athletes (TCA SHN)

TCA SHN
Start date: June 2010
Phase: N/A
Study type: Observational

Athletes in particular elite athletes have obsessional food and body concerns, in bond with a worship of the performance more and more invading, which lead to clinical and subclinical eating disorders. These eating disorders differ according to the disciplines and are difficult to diagnose in athletes because there are insufficiently described. Our aim at estimating the frequency of eating disorders in athletes and describing eating disorders by means of somatic, dietetic and psychological evaluations.

NCT ID: NCT01543867 Completed - Turner Syndrome Clinical Trials

Safety and Efficacy of Long-term Somatropin Treatment in Children

GrowthWIN II
Start date: January 2001
Phase: N/A
Study type: Observational

This study is conducted in Europe. The aim of this study is to evaluate safety during the long-term use of somatropin (Norditropin®) in children as well as efficacy on change in height. A subgroup of children small for their gestational age is included.

NCT ID: NCT01543724 Withdrawn - Bipolar Disorder Clinical Trials

Neural Correlates for Therapeutic Mechanisms of Lithium in Bipolar Disorder

Start date: June 1, 2015
Phase: Phase 4
Study type: Interventional

The investigators will assess Li-induced gray matter volume changes with regard to the endophenotype of GSK3beta polymorphism. The changes of gray matter are supposed to be more attributable to neurotrophic and neuroprotective characteristics of Li, which were closely related to the inhibition of apoptotic activity of GSK3beta.

NCT ID: NCT01542957 Completed - Clinical trials for Major Depressive Disorder

Cognitive Therapy for Unipolar Depression: Efficacy of a Dilemma-Focused Intervention

Start date: November 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the efficacy of a brief psychological intervention focused on the personal dilemmas identified for each depressive patient. For that, this intervention is combined to group cognitive therapy (an already proven efficacious format) and compared to cognitive individual therapy.

NCT ID: NCT01542528 Completed - Clinical trials for Attention Deficit Hyperactivity Disorder (ADHD)

Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)

IBBS
Start date: March 2012
Phase: N/A
Study type: Interventional

The investigators are conducting this randomized trial to determine if IBBS (Integrated Brain, Body, and Social)intervention is an effective treatment for ADHD (attention Deficit Hyperactivity Disorder) in two culturally distinct settings; Hamden and New Haven, Connecticut and Beijing, China. A subgroup of the children in the US will also participate in an EEG study before and after IBBS and will be compared to a group of typically developing children. IBBS combines computer-presented brain exercises with a physical education curriculum, all of which is designed to be fun, as well as to enhance sustained attention, inhibitory control and other executive capacities. IBBS is a school-based program in which groups children (composed of children with ADHD, children at risk for ADHD, and typically developing children) alternate between a classroom setting and the gymnasium four days a week for 15 weeks. These mixed age groups will be composed of children with ADHD, children at-risk for ADHD, and typically developing children. Although IBBS takes place in a group setting, the computer game component individualizes instruction to maximize benefit for each child. During the last year of the grant, we will be introducing a pilot study of an organizational skills training (OST) that will provide individualized parent and child training for improved executive functioning in children randomized to the OST plus home-based program.